Table 7 Sensitivity analyses for prescription of ULT and for ULT adherence >80 %, additionally adjusting for patient preference for pharmacological vs. non-pharmacological treatments

Gender

P = 0.58

P = 0.12

   Male

0.90 (0.58, 1.38)

2.10 (0.81, 5.44)

   Female

Ref

Ref

Age groups

P = 0.98

P = 0.91

   21–40 years

0.82 (0.24, 2.82)

0.89 (0.08, 10.2)

   41–60 years

0.88 (0.28, 2.71)

1.00 (0.11, 9.31)

   61–80 years

0.92 (0.29, 2.91)

1.27 (0.13, 12.00)

   >80 years

Ref

Ref

Race

P = 0.99

P = 0.64

   African American

1.01 (0.50, 2.04)

0.25 (0.03, 1.97)

   Hispanic or Latino

1.37 (0.46, 4.05)

0.85 (0.09, 7.83)

   Asian

1.12 (0.59, 2.12)

1.96 (0.72, 5.31)

   American Indian or Alaskan native

-----

---

   Hawaiian or Pacific Islander

1.84 (0.40, 8.42)

1.96 (0.17, 23.00)

   Other

0.90 (0.58, 2.78)

1.61 (0.29, 8.86)

   White/Caucasian

Ref

Ref

Choice of preferred therapy for gout

   Non-ULT

1.00 (0.69, 1.46)**

1.02 (0.51, 2.04)***

   ULT

Ref

Ref